Breaking News

Axplora Announces €6.5 Million Investment at Vizag Site

The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ingredients.

By: Rachel Klemovitch

Assistant Editor

Axplora, a global provider of API small molecule manufacturing, announced a significant investment at its Vizag site in India to expand production capacity and reinforce supply chain resilience. This announcement follows the successful completion of routine U.S. FDA inspections in 2025 at both of Axplora’s Indian manufacturing sites, Vizag and Chennai, which form part of the company’s PharmaZell Business Unit.  The expansion project at Vizag will increase output and create new employment oppo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters